Enhanced Ultrasound Superior to MRI for Diagnosing Certain Liver and Kidney Tumors, According to New Studies
Retrieved on:
Tuesday, February 21, 2023
Medical Devices, Hospitals, FDA, Clinical Trials, Health Technology, Cardiology, Biotechnology, Radiology, Health, Oncology, Medical school, Radiation, University, ICUS, Kidney disease, Sulfur hexafluoride, Diagnosis, Urology, Journal of Ultrasound in Medicine, Character, GE HealthCare, Anxiety, Malignancy, Gastroenterology, Journal, AASLD, CEUS, Patient, MRI, CT, Liver, American Association of Clinical Endocrinologists, Contrast-enhanced ultrasound, Liver cancer, JUM, Northeast Ohio Medical University, Cancer, Neoplasm, Hepatology, Medical imaging, Medical device, Veterinary medicine, Dietary supplement, Definity, Medicine
Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the Journal of Ultrasound in Medicine (JUM) and highlighted by the International Contrast Ultrasound Society (ICUS).
Key Points:
- Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the Journal of Ultrasound in Medicine (JUM) and highlighted by the International Contrast Ultrasound Society (ICUS).
- She called upon the American Association for the Study of Liver Diseases (AASLD) to include CEUS in its liver imaging guidelines, along with MRI and CT.
- The Canadian liver study represents the first prospective comparison of CEUS and contrast-enhanced MRI for assessment of newly-discovered liver nodules, according to Dr. Wilson.
- Nonetheless, MRI remains an essential tool for managing patients with malignant tumors, particularly for staging these tumors prior to treatment, according to Dr. Wilson.